Tero Järvinen
@terojarvinen.bsky.social
Professor & Chief Surgeon
Tero Järvinen, M.D., Ph.D.
Orthopedic sports medicine surgeon who got into molecular cell biology of tissue regeneration
Tero Järvinen, M.D., Ph.D.
Orthopedic sports medicine surgeon who got into molecular cell biology of tissue regeneration
December 2, 2025 at 4:14 PM
Dr. K. Kanto - Remarkable job! 👍👏 www.bmj.com/content/391/...
Arthroscopic subacromial decompression versus placebo surgery for subacromial pain syndrome: 10 year follow-up of the FIMPACT randomised, placebo surgery controlled trial
Objective To assess the long term efficacy of arthroscopic subacromial decompression (ASD) versus placebo surgery (diagnostic arthroscopy) and exercise therapy in patients with subacromial pain syndro...
www.bmj.com
December 2, 2025 at 4:13 PM
Dr. K. Kanto - Remarkable job! 👍👏 www.bmj.com/content/391/...
Fall Prevention Integrated Into Primary Health Care url: jamanetwork.com/journals/jam... Dr. Pekka Kannus was right; fall prevention should be a high priority. Remarkable results with simple intervention.
Fall Prevention Integrated Into Primary Health Care
This cluster randomized trial assesses whether integrating a fall prevention program in a primary care health system compared with usual care reduces self-reported falls among rural-dwelling older adu...
jamanetwork.com
November 20, 2025 at 12:38 PM
Fall Prevention Integrated Into Primary Health Care url: jamanetwork.com/journals/jam... Dr. Pekka Kannus was right; fall prevention should be a high priority. Remarkable results with simple intervention.
Here is my interview for the Innovation Award by the Finnish Medical Foundation:
laaketieteensaatio.fi/tero-jarvise...
laaketieteensaatio.fi/tero-jarvise...
Tero Järvisen johdolla kehitetty lääkemolekyyli voi tuoda uutta apua vakavasta ihosairaudesta kärsiville | Suomen Lääketieteen Säätiö
<div class="at-above-post addthis_tool" data-url="https://laaketieteensaatio.fi/tero-jarvisen-johdolla-kehitetty-laakemolekyyli-voi-tuoda-uutta-apua-vakavasta-ihosairaudesta-karsiville/"></div>Epiderm...
laaketieteensaatio.fi
November 13, 2025 at 1:28 PM
Here is my interview for the Innovation Award by the Finnish Medical Foundation:
laaketieteensaatio.fi/tero-jarvise...
laaketieteensaatio.fi/tero-jarvise...
Honored to be considered (and proposed by someone) for this prestigious award. www.sttinfo.fi/tiedote/7160...
Tässä ovat kärkiehdokkaat Pohjolan lääketieteen innovaatiopalkinnon saajaksi | Suomen Lääketieteen Säätiö
Tunnustus jaetaan ensimmäisen kerran Helsingin Lääkäripäivillä tammikuussa 2026. Lopullisen palkinnonsaajan valitsee pitkän linjan yrittäjä, Planmecan perustajana tunnettu Heikki Kyöstilä.
www.sttinfo.fi
November 13, 2025 at 12:47 PM
Honored to be considered (and proposed by someone) for this prestigious award. www.sttinfo.fi/tiedote/7160...
Reposted by Tero Järvinen
The protein LRG1 acts as a critical player in the initial onset of diabetic retinopathy by disrupting TGF-beta signaling in pericytes and triggering pathological constriction of capillaries, according to new #ScienceTranslationalMedicine work in mice. https://scim.ag/3Jx6NRu
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in mice
LRG1-driven microvascular dysfunction triggers early diabetic retinopathy, highlighting a potential therapeutic target.
scim.ag
November 3, 2025 at 7:00 PM
The protein LRG1 acts as a critical player in the initial onset of diabetic retinopathy by disrupting TGF-beta signaling in pericytes and triggering pathological constriction of capillaries, according to new #ScienceTranslationalMedicine work in mice. https://scim.ag/3Jx6NRu
Dr. Tuomas Komulainen, M.D. wrapped up his PhD Thesis demonstrating that the recruitment of anti-inflammatory M2 macrophages are important for keloid resolution after corticosteroid injections. A double-blinded RCT. J Invest Dermatol www.jidonline.org/article/S002... @thejidjournal.bsky.social
Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled tri...
We explored the predictive value of immune cell populations to intra-lesional injections
by using biopsies collected from the active border of keloids before and after injections
in the double-blinded...
www.jidonline.org
November 5, 2025 at 5:48 AM
Dr. Tuomas Komulainen, M.D. wrapped up his PhD Thesis demonstrating that the recruitment of anti-inflammatory M2 macrophages are important for keloid resolution after corticosteroid injections. A double-blinded RCT. J Invest Dermatol www.jidonline.org/article/S002... @thejidjournal.bsky.social
Dr. Tuomas Komulainen wrapped up his PhD Thesis demonstrating that the recruitment of anti-inflammatory M2 macrophages are important for keloid resolution after corticosteroids. A double-blinded, randomized, controlled trial - Journal of Investigative Dermatology www.jidonline.org/article/S002...
Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled tri...
We explored the predictive value of immune cell populations to intra-lesional injections
by using biopsies collected from the active border of keloids before and after injections
in the double-blinded...
www.jidonline.org
November 5, 2025 at 5:32 AM
Dr. Tuomas Komulainen wrapped up his PhD Thesis demonstrating that the recruitment of anti-inflammatory M2 macrophages are important for keloid resolution after corticosteroids. A double-blinded, randomized, controlled trial - Journal of Investigative Dermatology www.jidonline.org/article/S002...
Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled trial - Journal of Investigative Dermatology www.jidonline.org/article/S002...
Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled tri...
We explored the predictive value of immune cell populations to intra-lesional injections
by using biopsies collected from the active border of keloids before and after injections
in the double-blinded...
www.jidonline.org
November 4, 2025 at 2:35 PM
Anti-inflammatory macrophages are recruited to the keloids that obtain response to intra-lesional injection therapies Pre- and post-treatment biopsies from a double-blinded, randomized, controlled trial - Journal of Investigative Dermatology www.jidonline.org/article/S002...
A new drug screening method could bring a solution to drug delivery and efficacy issues | EurekAlert! www.eurekalert.org/news-release...
A new drug screening method could bring a solution to drug delivery and efficacy issues
A method developed by a research group at Tampere University seeks specific molecules that can target desired tissues through the bloodstream and penetrate tissues by passing through cells. This innov...
www.eurekalert.org
October 30, 2025 at 4:40 AM
A new drug screening method could bring a solution to drug delivery and efficacy issues | EurekAlert! www.eurekalert.org/news-release...
I am happy to announce that our article on skeletal muscle morphology and its importance to sports injuries is out: Issue 49 - 'football medicine & performance' issuu.com/lmeda/docs/i... käyttäen @issuuzzz.bsky.social.
Issue 49 - 'football medicine & performance'
As the 2025/2026 season gets underway, we are pleased to present a new edition of Football Medicine and Performance, featuring a diverse range of articles designed to inform and support your clinical
issuu.com
October 11, 2025 at 8:59 AM
I am happy to announce that our article on skeletal muscle morphology and its importance to sports injuries is out: Issue 49 - 'football medicine & performance' issuu.com/lmeda/docs/i... käyttäen @issuuzzz.bsky.social.
Reposted by Tero Järvinen
September 19, 2025 at 12:43 PM
Reposted by Tero Järvinen
September 19, 2025 at 12:44 PM
Dr Afsaneh Ehsandoost come to my lab as a EDUFI-student. Happy to announce the publication of the chitosan scaffolds she created: a novel approach to mimicking native skin architecture doi.org/10.1088/1748...
via @ioppublishing.bsky.social
via @ioppublishing.bsky.social
Bilayered chitosan scaffolds: a novel approach to mimicking native skin architecture - IOPscience
Bilayered chitosan scaffolds: a novel approach to mimicking native skin architecture, Ehsandoost, Afsaneh, Järvinen, Tero A. H., Tamjid, Elnaz
doi.org
September 10, 2025 at 5:27 AM
Dr Afsaneh Ehsandoost come to my lab as a EDUFI-student. Happy to announce the publication of the chitosan scaffolds she created: a novel approach to mimicking native skin architecture doi.org/10.1088/1748...
via @ioppublishing.bsky.social
via @ioppublishing.bsky.social
Reposted by Tero Järvinen
A new #ScienceTranslationalMedicine study reveals how S. aureus skews the skin immune response toward an inflammatory IL-17 signature involving CD4+ and MAIT cells in children with RDEB, and sheds light on the link between different strains and disease severity. https://scim.ag/4p30fu0
Immune response and clinical severity are shaped by skin-adapted Staphylococcus aureus in chronically infected patients
T cells produce IL-17 in RDEB-associated severe inflammatory dermatosis.
scim.ag
September 1, 2025 at 6:00 PM
A new #ScienceTranslationalMedicine study reveals how S. aureus skews the skin immune response toward an inflammatory IL-17 signature involving CD4+ and MAIT cells in children with RDEB, and sheds light on the link between different strains and disease severity. https://scim.ag/4p30fu0
Reposted by Tero Järvinen
📢 REMINDER
The final registration deadline for the forthcoming #ETRS2025 Conference in Cardiff (UK) is on Friday, 15th August.
Be sure to register here: etrs2025.eu/registration/
We are looking forward to having you join us!
The final registration deadline for the forthcoming #ETRS2025 Conference in Cardiff (UK) is on Friday, 15th August.
Be sure to register here: etrs2025.eu/registration/
We are looking forward to having you join us!
August 6, 2025 at 7:09 AM
📢 REMINDER
The final registration deadline for the forthcoming #ETRS2025 Conference in Cardiff (UK) is on Friday, 15th August.
Be sure to register here: etrs2025.eu/registration/
We are looking forward to having you join us!
The final registration deadline for the forthcoming #ETRS2025 Conference in Cardiff (UK) is on Friday, 15th August.
Be sure to register here: etrs2025.eu/registration/
We are looking forward to having you join us!
Reposted by Tero Järvinen
#ETRS2025 Annual Meeting Speaker Spotlight
🧬 SESSION 9: Exploiting Biologics for Enhanced Healing
Last but not least, join us for an exciting keynote lecture by Dr Ning Xu Landén (Karolinska Institutet, Sweden).
"Decoding the RNA Regulome of Human Skin Wound Healing – Towards Future Wound Care”
🧬 SESSION 9: Exploiting Biologics for Enhanced Healing
Last but not least, join us for an exciting keynote lecture by Dr Ning Xu Landén (Karolinska Institutet, Sweden).
"Decoding the RNA Regulome of Human Skin Wound Healing – Towards Future Wound Care”
August 5, 2025 at 5:01 AM
#ETRS2025 Annual Meeting Speaker Spotlight
🧬 SESSION 9: Exploiting Biologics for Enhanced Healing
Last but not least, join us for an exciting keynote lecture by Dr Ning Xu Landén (Karolinska Institutet, Sweden).
"Decoding the RNA Regulome of Human Skin Wound Healing – Towards Future Wound Care”
🧬 SESSION 9: Exploiting Biologics for Enhanced Healing
Last but not least, join us for an exciting keynote lecture by Dr Ning Xu Landén (Karolinska Institutet, Sweden).
"Decoding the RNA Regulome of Human Skin Wound Healing – Towards Future Wound Care”
Reposted by Tero Järvinen
ETRS2025 Annual Meeting Speaker Spotlight
🧱 SESSION 8: Matrix Modulation For Tissue Repair
We are thrilled to host Professor @terojarvinen.bsky.social (Tampere University Hospital, Finland) at #ETRS2025.
Don’t miss this game-changing lecture on targeted tissue repair therapies!
#Matrixbiology
🧱 SESSION 8: Matrix Modulation For Tissue Repair
We are thrilled to host Professor @terojarvinen.bsky.social (Tampere University Hospital, Finland) at #ETRS2025.
Don’t miss this game-changing lecture on targeted tissue repair therapies!
#Matrixbiology
July 29, 2025 at 5:32 PM
ETRS2025 Annual Meeting Speaker Spotlight
🧱 SESSION 8: Matrix Modulation For Tissue Repair
We are thrilled to host Professor @terojarvinen.bsky.social (Tampere University Hospital, Finland) at #ETRS2025.
Don’t miss this game-changing lecture on targeted tissue repair therapies!
#Matrixbiology
🧱 SESSION 8: Matrix Modulation For Tissue Repair
We are thrilled to host Professor @terojarvinen.bsky.social (Tampere University Hospital, Finland) at #ETRS2025.
Don’t miss this game-changing lecture on targeted tissue repair therapies!
#Matrixbiology
Reposted by Tero Järvinen
Some journals are claiming that you need to pay big $$ for gold open access to comply with NIH's new public access policy. FYI that is total bs. You can comply by depositing the Accepted Manuscript into PubMed Central on the Date of Publication without embargo. Pass it on.
July 26, 2025 at 12:52 AM
Some journals are claiming that you need to pay big $$ for gold open access to comply with NIH's new public access policy. FYI that is total bs. You can comply by depositing the Accepted Manuscript into PubMed Central on the Date of Publication without embargo. Pass it on.
Reposted by Tero Järvinen
ETRS2025 Annual Meeting Speaker Spotlight
🦠 SESSION 4: Scarring and Wound Regeneration
We are excited to welcome Dr. Claire Higgins from Imperial College London as a keynote speaker!
Guest speaker Dr. Soma Meran will follow.
Innovative science meets clinical impact!
#ETRS2025
🦠 SESSION 4: Scarring and Wound Regeneration
We are excited to welcome Dr. Claire Higgins from Imperial College London as a keynote speaker!
Guest speaker Dr. Soma Meran will follow.
Innovative science meets clinical impact!
#ETRS2025
July 23, 2025 at 3:11 PM
ETRS2025 Annual Meeting Speaker Spotlight
🦠 SESSION 4: Scarring and Wound Regeneration
We are excited to welcome Dr. Claire Higgins from Imperial College London as a keynote speaker!
Guest speaker Dr. Soma Meran will follow.
Innovative science meets clinical impact!
#ETRS2025
🦠 SESSION 4: Scarring and Wound Regeneration
We are excited to welcome Dr. Claire Higgins from Imperial College London as a keynote speaker!
Guest speaker Dr. Soma Meran will follow.
Innovative science meets clinical impact!
#ETRS2025
Reposted by Tero Järvinen
ETRS2025 Annual Meeting Speaker Spotlight
💊 SESSION 5: Drug Development for Wound Healing | QBiotics Symposium
From Australia to Cardiff — Dr Paul Reddell, QBiotics Group Limited, with Jason K Cullen and Emma Woods, will join us at #ETRS2025.
A must attend!
💊 SESSION 5: Drug Development for Wound Healing | QBiotics Symposium
From Australia to Cardiff — Dr Paul Reddell, QBiotics Group Limited, with Jason K Cullen and Emma Woods, will join us at #ETRS2025.
A must attend!
July 23, 2025 at 3:13 PM
ETRS2025 Annual Meeting Speaker Spotlight
💊 SESSION 5: Drug Development for Wound Healing | QBiotics Symposium
From Australia to Cardiff — Dr Paul Reddell, QBiotics Group Limited, with Jason K Cullen and Emma Woods, will join us at #ETRS2025.
A must attend!
💊 SESSION 5: Drug Development for Wound Healing | QBiotics Symposium
From Australia to Cardiff — Dr Paul Reddell, QBiotics Group Limited, with Jason K Cullen and Emma Woods, will join us at #ETRS2025.
A must attend!
Reposted by Tero Järvinen
These parents set up biotechnology companies, hoping to cure their children's illnesses
go.nature.com/4o0hV92
go.nature.com/4o0hV92
Meet the biotech-company founders driven by their child’s rare disease
For some parents, finding a cure for their child’s illness is the ultimate motivation to start a company.
go.nature.com
July 21, 2025 at 12:55 PM
These parents set up biotechnology companies, hoping to cure their children's illnesses
go.nature.com/4o0hV92
go.nature.com/4o0hV92